Pradžia › Krono liga › Wisconsin
Krono liga klinikiniai tyrimai Wisconsin
7 tyrimai dėl Krono liga ieško dalyvių vietose Wisconsin.
Miestai Wisconsin
Oficialus tyrimo tekstas (anglų kalba)
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Wisconsin Center for Advanced Research, Milwaukee
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Froedtert Hospital and the Medical College of Wisconsin-Site Number: 8400081, Milwaukee
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184931Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Medical College of Wisconsin, Milwaukee
Renkami dalyviai4 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-05-27 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Medical College of Wisconsin Cancer Center - Froedtert Hospital, Milwaukee
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-27 · NCT06227910Precise Infliximab Exposure and Pharmacodynamic Control
- Medical College of Wisconsin, Children's of Wisconsin, Milwaukee
Renkami dalyviai2/3 fazė
Amžius nuo 6 iki 22 · Visoms lytims · Atnaujinta 2026-05-05 · NCT05660746A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Milwaukee
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-03-12 · NCT07113522Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Brain Inflammation Collaborative, Delafield
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-01-22 · NCT04806620Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.